澳门葡京手机版app下载 for ansatte ved MED - Side 35
The Centre for Global Health is leading a debate in the 6th German-African Healthcare Forum, co-organized by German-African Business Association (Afrika-Verein) and the German Health Alliance.
Women in Global Health is an organization, built on a global movement that brings together all genders and backgrounds to achieve gender equality in global health leadership. The German-African Business Association (Afrika-Verein), GHA – German Health Alliance and Women in Global Health Norway with the support of EZ-Scout, are pleased to host a breakfast event to introduce Women in Global Health and provide updates of current news.
The Centre for Global Health is organizing a lunch panel at the World Health Summit 2019, exploring different views on One Health with a variety of experts in the field. One Health is closely aligned with the Sustainable Development Goals and is intrinsically inter- and trans-disciplinary.
The Centre for Global Health is organizing a high-level panel debate at the World Health Summit 2019. We are harnessing the long-standing and continued collaboration in Global Health between Germany, Norway and Ghana and will explore whether One Health has the potential of becoming an accelerator to the Global Action Plan.
Speaker: Maud Fagny, Postdoctoral fellow, Le Moulon, French National Institute for Agricultural Research (INRA), Paris-Sud University, France and French National Center for Scientific Research (CNRS), AgroParisTech, University of Paris-Saclay, France
The Division of Critical Care invites you to a conference on "Biomarkers in research symptoms" at Laboratoriebygget, Ullev?l, Oslo University Hospital.
This symposium brings together world leaders in the ER proteostasis field in Oslo to showcase new research in this burgeoning field and its links to different aspects of normal cellular function as well as disease states, and aims stimulate new collaborative research.
SERAF avholder universitetskurs i rusmiddelmedisin over til sammen fire dager. Kurset er delt opp i en grunnlagsmodul og en behandlingsmodul. Kurset tar sikte p? ? ?ke kompetansen i behandling og oppf?lging av pasienter med rusmiddelrelaterte problemer.
Repurposing of drugs can potentially bring medications with known safety profiles to new patient groups. What is the industry looking for when they consider to invest in a repurposing project? What is the regulatory framework in this area? How is IP handled?
